Network quantification of EGFR signaling unveils potential for targeted combination therapy

The epidermal growth factor receptor (EGFR) signaling network is activated in most solid tumors, and small-molecule drugs targeting this network are increasingly available. However, often only specific combinations of inhibitors are effective. Therefore, the prediction of potent combinatorial treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Klinger, Bertram, Sieber, Anja, Fritsche-Guenther, Raphaela, Witzel, Franziska, Berry, Leanne, Schumacher, Dirk, Yan, Yibing, Durek, Pawel, Merchant, Mark, Schäfer, Reinhold, Sers, Christine, Blüthgen, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Molecular Biology Organization 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964313/
https://www.ncbi.nlm.nih.gov/pubmed/23752269
http://dx.doi.org/10.1038/msb.2013.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964313/
https://www.ncbi.nlm.nih.gov/pubmed/23752269
http://dx.doi.org/10.1038/msb.2013.29

Ejemplares similares